Rotavirus Infection in a Secondary Hospital, Laboratory Diagnosis and Impact of Immunization on Pediatric Hospitalization Saudi Arabia

Riyad ALkheliaf¹, Mohammed. A. Garout², Magda R. Abdelwadood^3, , Amer Alkhlaif⁴ and Mayad R. Khelaif⁵

¹Senior consultant Paediatric Infectious Diseases, King Saud Medical City (KSMC) / Sanad Hospital KSA

²Community Medicine and Public Health, Faculty of Medicine, Umm Al-Qura University, Makkah, K.S.A

³Microbiology and Immunology, Faculty of Medicine, ain Shams, University, Cairo, Laboratory consultant Sanad Hospital, KSA

⁴Medical Student, Almarefa Medical Collegue

⁵Medical intern, King Fahad Medical City

Cite this paper:
Riyad ALkheliaf, Mohammed. A. Garout, Magda R. Abdelwadood, Amer Alkhlaif and Mayad R. Khelaif. Rotavirus Infection in a Secondary Hospital, Laboratory Diagnosis and Impact of Immunization on Pediatric Hospitalization Saudi Arabia. American Journal of Epidemiology and Infectious Disease. 2017; 5(2):21-26. doi: 10.12691/ajeid-5-2-1

Abstract

Rotavirus is the most common cause of gastroenteritis (diarrhea) disease among infants and young children, Rotavirus is usually an easily managed disease of childhood, infections are most common during the winter months from November to May. However, infection with rotavirus can occur anytime of the year, There are currently 2 FDA-approved rotavirus vaccines to protect against rotavirus gastroenteritis (RotaTeq and Rotarix). These vaccines are indicated in infants aged 6-32 weeks (RotaTeq) and those aged 6-24 weeks (Rotarix). OBJECTIVES: Conduct viral testing on stool samples from diarrhea patients to determine ROTA viruses that as a cause of diarrhea, and effectiveness of vaccine. STUDY DESIGN: A retrospective cross section study was conducted using stool samples collected from children with diarrhea (n=285) between January 2015 and December 2016. Samples were tested for rotavirus, were determined by Enzyme immunoassay, Latex agglutination. Result: two hundred eighty five stool samples from children with acute diarrhea attend to our hospital in 2015 and 2016 were examined by commercial latex and immunoenzymatic assays for the diagnosis of rotavirus infection in laboratories. for comparison, sensitivity and specificity for the latex and ELISA assays ELISA and Latex Test specificity 98.5 % Latex sensitivity 88 % to ELISA. Around 16% of our study population with diarrhea disease were diagnosed as ROTA (45/285) AMONGE THEM 89% 40/54were previous vaccinated with RTOTARIX CONCLUSION Rotavirus is an infection that causes diarrhea. It's the most common cause of diarrhea in infants and children less than 5 years old worldwide, according to the Centers for CDC Rotavirus vaccines are very effective at preventing rotavirus disease, However in our study we found most of patients were vaccinated according to national vaccination program still had a disease and the vaccination only modified disease course decrease days of hospitalization for further expanded and comparative study for types of vaccination.

Keywords:
acute gastroenteritis diarrhea oral vaccine rotavirus vaccine

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Payne DC, Baggs J, Zerr DM, et al. Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis 2014; 58: 173.
[2]	http://www.sahealth.sa.gov.au/wps/wcm/connect/Public+Content/SA+Health+In Jun 2016.
[3]	Tate, Jacqueline E.; Burton, Anthony H.; Boschi-Pinto, Cynthia; Parashar, Umesh D. (2016). "Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013". Clinical Infectious Diseases. 62 (Suppl 2): S96–S105.
[4]	Doro, R., Farkas, S. L., Martella, V. & Banyai, K. Zoonotic transmission of rotavirus: surveillance and control. Expert Rev. Anti Infect.Ther. 13, 1337-1350 (2015).
[5]	World Health Organization (2008). "Global networks for surveillance of rotavirus gastroenteritis, 2001-2008" (PDF). Weekly Epidemiological Record. 83 (47): 421-428. Retrieved 3 May 2012
[6]	World Health Organization, Department of Vaccines and Biologicals. “Introduction of Rotavirus Vaccines into National Immunization Programs: Management manual including operational information for health workers”. Geneva 2008. introduction.
[7]	http://www.mayoclinic.org/diseases-conditions/rotavirus/symptoms-causes/dxc-20186931 (2016).
[8]	http://www.sahealth.sa.gov.au/wps/wcm/connect/Public+Content/SA+Health+In Jun 2016
[9]	Celik, C., Gozel, M.G., Turkay, H., et al. (2015) Rotavirus and Adenovirus Gastroenteritis: Time Series Analysis. Pediatrics International, 57, 590-596.
[10]	CDC August 12, 2016 Content source: National Center for Immunization and Respiratory Diseases, Division of Viral Diseases.
[11]	Rosillon D, Buyse H, Friedland LR, Ng SP, Velázquez FR, Breuer T. 2015Risk of Intussusception After Rotavirus Vaccination: Meta-analysis of Postlicensure Studies. Pediatr Infect Dis J. 2015 Jul; 34(7): 763-8.
[12]	www.biomerieux-diagnostics.com).
[13]	Dennehy PH (2015). "Rotavirus Infection: A Disease of the Past?". Infectious Disease Clinics of North America. 29 (4): 617-35.
[14]	Simpson E, Wittet S, Bonilla J, Gamazina K, Cooley L, Winkler JL (2007). "Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries". BMC Public Health. 7: 281.
[15]	Al-Marzoqi, A.H., Shemmran, A.R. and Al-Nafee’, M.K. (2010). Role of Rotavirus and Adenovirus in Acute Infantile Gastroenteritis in Infants Younger than One Year of Age in Babylon Province. Journal of Al-Qadisiyah for PureScience, 15, 1-7.
[16]	Khalil, M., Azhar, E. and Kao, M. (2015) Gastroenteritis Attributable to Rotavirus in Hospitalized Saudi ArabianChildren in the Period 2007-2008. Clinical Epidemiology, 7, 129-137.
[17]	Motamedifar, M., Amini, E. and Shirazi, P.T. (2013) Frequency of Rotavirus and Adenovirus Gastroenteritis amongChildren in Shiraz, Iran. Iranian Red Crescent Medical Journal, 15, 729-733.
[18]	Dilshad O. Jaff1, Tariq A. G. Aziz2, Natalie R. Smith3: 2016 The Incidence of Rotavirus andAdenovirus Infections among Children with Diarrhea in Sulaimani Province, Iraq; Journal of Biosciences and Medicines, 2016, 4, 124-131.
[19]	Mark Zeller1, Valerie Nuyts1, Elisabeth Heylen1, Sarah De Coster1, Nádia Conceição-Neto1,2,, 2016: Emergence of human G2P[4] rotaviruses containing animal derived gene segments in the post-vaccine era; Journal of virology 84, Published: 14 November 2016.
[20]	World Health Organization, Department of Vaccines and Biologicals. “Introduction of Rotavirus Vaccines into National Immunization Programs: Management manualincluding operational information for health workers”. Geneva 2010.
[21]	CDC http://www.who.int/immunization/topics/rotavirus/en/ 2010.
[22]	Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomized, double-blind controlled study. Lancet 2007; 370: 1757.
[23]	Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2009; 58: 1-26.
[24]	WHO Organization, W. H. Vaccine Preventable Diseases Surveillance. Global Rotavirus Surveillance and Information Bulletin. Vol. 10, Data period 2013 http://www.who.int/immunization/monitoring_surveillance/resources/WHO_Global_RV_Surv_Bulletin_Jan_ 2015_Final.pdf (2016).
[25]	Forster, J.; Guarino, A.; Parez, N.; Moraga, F.; Roman, E.; Mory, O.; Tozzi, A.E.; de Aguileta, A.L.; wahn, U.; Graham, C.; Berner, R.; Ninan, T.; Barberousse, C.; Meyer, N. and Soriano-Gabarro, M. The rotavirus study group. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics, 2009; 123 (3): 393-400.
[26]	Malek, M.A.; Teleb, N.; Abu-Elyazeed,R.; Riddle, M.S.; Sherif, M.E.; Steele, A.D.; Glass, R.I. and Bresee, J.S. The epidemiology of rotavirus diarrhea in countries in the Eastern Mediterranean Region. J. infect. Dis. 2010; 202 Suppl: S12-22.
[27]	Paulke-Korinek, M. et al. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria. Vaccine 31, 2686-2691.
[28]	Dennis, A. F. et al. Molecular epidemiology of contemporary G2P[4] human rotaviruses cocirculating in a single U.S. community: footprints of a globally transitioning genotype. Journal of virology 88, 3789-3801, (2014).